EDGAR Filing Documents for 0001144204-08-012265

Form 8-K - Current report:

SEC Accession No. 0001144204-08-012265

Filing Date

2008-02-28

Accepted

2008-02-28 14:42:18

Documents

Period of Report

2008-02-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		v105348_8-k.htm	8-K	38863
2		v105348_ex99-1.htm	EX-99.1	16561
3		v105348_ex99-2.htm	EX-99.2	18445
	Complete submission text file	0001144204-08-012265.txt		75751

Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019

Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950

MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)